Joel Beatty
Stock Analyst at Robert W. Baird
Total Price Targets
26
Stocks Covered
16
Sectors
Consumer Defensive, Healthcare
Most Recent
Dec 29, 2025
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Joel Beatty
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc. | $47.00 | $24.79 | +89.6% | 2 | Dec 29, 2025 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $19.00 | $16.04 | +18.5% | 3 | Oct 16, 2025 |
| LRMR | Larimar Therapeutics, Inc. | $7.00 | $3.98 | +76.1% | 1 | Sep 30, 2025 |
| PTCT | PTC Therapeutics, Inc. | $70.00 | $65.06 | +7.6% | 3 | Aug 8, 2025 |
| AXSM | Axsome Therapeutics, Inc. | $162.00 | $204.09 | -20.6% | 3 | May 6, 2025 |
| NGNE | Neurogene Inc. | $38.00 | $27.11 | +40.2% | 2 | Mar 25, 2025 |
| CPRX | Catalyst Pharmaceuticals, Inc. | $28.00 | $28.77 | -2.7% | 1 | Feb 4, 2025 |
| JAZZ | Jazz Pharmaceuticals plc | $162.00 | $202.38 | -20.0% | 1 | Nov 18, 2024 |
| EDIT | Editas Medicine, Inc. | $10.00 | $2.91 | +243.6% | 2 | Oct 22, 2024 |
| ELF | e.l.f. Beauty, Inc. | $175.00 | $60.35 | +190.0% | 2 | Oct 21, 2024 |
| CTNM | Contineum Therapeutics, Inc. Class A Common Stock | $32.00 | $13.38 | +139.2% | 1 | Oct 21, 2024 |
| ACAD | ACADIA Pharmaceuticals Inc. | $28.00 | $21.95 | +27.5% | 1 | May 9, 2024 |
| GERN | Geron Corporation | $4.50 | $1.58 | +183.9% | 1 | Apr 30, 2024 |
| NRIX | Nurix Therapeutics, Inc. | $25.00 | $16.83 | +48.5% | 1 | Apr 11, 2024 |
| ALKS | Alkermes plc | $37.00 | $33.49 | +10.5% | 1 | Mar 18, 2024 |
| CLDI | Calidi Biotherapeutics, Inc. | $9.00 | $0.22 | +4005.8% | 1 | Oct 9, 2023 |
Recent Activity
- Dec 29, 2025— Set$47.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
- Oct 16, 2025— Set$19.00price target onAMLX(Amylyx Pharmaceuticals, Inc.)
- Sep 30, 2025— Set$7.00price target onLRMR(Larimar Therapeutics, Inc.)
- Aug 8, 2025— Set$70.00price target onPTCT(PTC Therapeutics, Inc.)
- May 7, 2025— Set$66.00price target onPTCT(PTC Therapeutics, Inc.)
- May 6, 2025— Set$162.00price target onAXSM(Axsome Therapeutics, Inc.)
- Mar 25, 2025— Set$38.00price target onNGNE(Neurogene Inc.)
- Feb 4, 2025— Set$28.00price target onCPRX(Catalyst Pharmaceuticals, Inc.)
- Feb 3, 2025— Set$132.00price target onAXSM(Axsome Therapeutics, Inc.)
- Nov 27, 2024— Set$52.00price target onPTCT(PTC Therapeutics, Inc.)
- Nov 18, 2024— Set$162.00price target onJAZZ(Jazz Pharmaceuticals plc)
- Nov 18, 2024— Set$11.00price target onAMLX(Amylyx Pharmaceuticals, Inc.)
- Oct 22, 2024— Set$10.00price target onEDIT(Editas Medicine, Inc.)
- Oct 21, 2024— Set$32.00price target onCTNM(Contineum Therapeutics, Inc. Class A Common Stock)
- Oct 21, 2024— Set$175.00price target onELF(e.l.f. Beauty, Inc.)
- Aug 9, 2024— Set$240.00price target onELF(e.l.f. Beauty, Inc.)
- Jun 10, 2024— Set$54.00price target onNGNE(Neurogene Inc.)
- May 31, 2024— Set$72.00price target onRARE(Ultragenyx Pharmaceutical Inc.)
- May 9, 2024— Set$28.00price target onACAD(ACADIA Pharmaceuticals Inc.)
- Apr 30, 2024— Set$4.50price target onGERN(Geron Corporation)
Frequently Asked Questions
Who is Joel Beatty?
Joel Beatty is a stock analyst at Robert W. Baird covering 16 stocks primarily in Consumer Defensive, Healthcare. They have issued 26 price targets since Nov 8, 2021.
What stocks does Joel Beatty cover?
Joel Beatty currently covers 16 stocks, including AMLX, PTCT, AXSM, RARE, NGNE.
What is Joel Beatty's latest price target?
Joel Beatty's most recent price target was $47.00 on RARE (Ultragenyx Pharmaceutical Inc.), set on Dec 29, 2025.
What is Joel Beatty's highest price target?
Joel Beatty's highest issued price target is $240.00 on ELF, set on Aug 9, 2024.
More Analysts at Robert W. Baird
Coverage based on publicly published price targets. Not investment advice.